Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
New findings published in RSNA's Radiology highlight the shortcomings of using nodule characteristics and patient history alone to predict an individual’s true cancer risk.
It is estimated that less than 20% of eligible patients in the U.S. adhere to LCS recommendations, despite numerous studies highlighting the exam’s effectiveness.
Chest X-rays could be the key to mitigating the issue of overdiagnosis in certain patient populations undergoing lung cancer screening, according to new research.
Dana Smetherman, MD, is a diagnostic radiologist who specializes in breast imaging. She spoke to Health Imaging about some key issues that have her attention in 2024 and beyond.
That number is expected to grow even more in the coming years, as the exam serves as a noninvasive alternative to colonoscopy, while also providing more accurate results than stool tests.
Despite kicking their initial habit, these individuals remain at risk of developing lung cancer due to their history of smoking cigarettes, current use of e-cigarettes, or both, experts caution.
The WISEWOMAN program proved to be a useful intervention to screen low-income, uninsured women and offer them risk reduction counseling to improve blood pressure, diet and physical activity.